info@seagull-health.com
SeagullHealth
语言:
search
Who can use Daurismo(Glasdegib)?
The specific medical condition the drug is approved to treat.
Who can use Daurismo(Glasdegib)?
DAURISMO is indicated in combination with low-dose cytarabine for the treatment of newly diagnosed acute myeloid leukemia (AML) in adult patients. This use is specifically for individuals who are 75 years of age or older or who have significant comorbidities that preclude the use of intensive induction chemotherapy.
Related Columns
Daurismo(Glasdegib)
DAURISMO is indicated in combination with low-dose cytarabine for the treatment...
WeChat Scan
Free Inquiry
Free Inquiry
Related articles
共 0 条
- 1
Departments
New Articles
New Drugs
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
- Core products
- Antitumor drugs
- General drug
- Antiviral drugs
- Biological agents
Contact Us
- mailbox：info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved